Holen Sie sich die Stockscreener-App
61.97
1.37%
0.84
Handel nachbörslich:
61.97
Schlusskurs vom Vortag:
$61.13
Offen:
$61.13
24-Stunden-Volumen:
471.19K
Relative Volume:
1.13
Marktkapitalisierung:
$1.92B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$131.74M
KGV:
14.72
EPS:
4.21
Netto-Cashflow:
$166.13M
1W Leistung:
-1.87%
1M Leistung:
-9.89%
6M Leistung:
-13.87%
1J Leistung:
-23.30%
1-Tages-Spanne:
$61.13
$63.04
1-Wochen-Bereich:
$59.50
$63.88
52-Wochen-Spanne:
$59.50
$86.96
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Vergleichen Sie CNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
61.97 | 1.92B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
CONMED (NYSE:CNMD) Sets New 52-Week LowWhat's Next? - MarketBeat
Olympiad Research LP Makes New $340,000 Investment in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Purchased by Principal Financial Group Inc. - MarketBeat
Allspring Global Investments Holdings LLC Grows Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Corporation Faces Rising Business Risks Amid Global Supply Chain Challenges - TipRanks
CONMED Corp SEC 10-K Report - TradingView
CONMED Co. (NYSE:CNMD) Short Interest Update - MarketBeat
Conmed's chief information officer sells $16,796 in common stock - MSN
Yousif Capital Management LLC Sells 285 Shares of CONMED Co. (NYSE:CNMD) - Defense World
CONMED Co. (NYSE:CNMD) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Conmed's chief information officer sells $16,796 in common stock By Investing.com - Investing.com Australia
CONMED Co. (NYSE:CNMD) Shares Sold by Choreo LLC - Defense World
abrdn plc Has $9.40 Million Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Prepare Yourself for Liftoff: Conmed Corp (CNMD) - SETE News
CONMED (NYSE:CNMD) Given New $91.00 Price Target at Needham & Company LLC - MarketBeat
CONMED (NYSE:CNMD) Price Target Lowered to $70.00 at Wells Fargo & Company - MarketBeat
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
CONMED (NYSE:CNMD) Downgraded to "Neutral" Rating by JPMorgan Chase & Co. - MarketBeat
CONMED (NYSE:CNMD) Given New $75.00 Price Target at Stifel Nicolaus - MarketBeat
CONMED (NYSE:CNMD) Issues Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
CONMED (NYSE:CNMD) Updates FY 2025 Earnings Guidance - MarketBeat
CONMED Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
Wells Fargo & Company Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Stifel Nicolaus Forecasts Strong Price Appreciation for CONMED (NYSE:CNMD) Stock - Defense World
Market Resilience: Conmed Corp (CNMD) Finishes Weak at 67.36, Down -8.97 - The Dwinnex
CONMED (NYSE:CNMD) Shares Gap Down After Analyst Downgrade - MarketBeat
Taking a look at what insiders are doing to gauge the Conmed Corp (CNMD)’s direction - Knox Daily
Behind Conmed Corp’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle
Needham & Company LLC Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Armenian Reporter
Breaking Down Conmed: 4 Analysts Share Their Views - Benzinga
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Needham cuts CONMED stock target to $91, maintains Buy rating - Investing.com
CONMED Corporation (NYSE:CNMD) Q4 2024 Earnings Call Transcript - Insider Monkey
CONMED Beats Analysts' Q4 Expectations Despite Full-Year Forecast ShortfallNews and Statistics - IndexBox, Inc.
These Analysts Slash Their Forecasts On Conmed After Q4 Results - Benzinga
JPMorgan cuts CONMED stock rating, lowers price target to $70 - Investing.com
Conmed: Q4 Earnings Snapshot - The Advocate
Conmed Corp (CNMD) Q4 2024 Earnings Call Highlights: Strong Growth in General Surgery and ... - Yahoo Finance
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings - MSN
CONMED earnings beat by $0.13, revenue topped estimates - Investing.com
Conmed Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops By Stock Story - Investing.com Canada
Conmed Q4 Earnings Assessment - Benzinga
Conmed Q4 Earnings Summary & Key Takeaways - Benzinga
Insights into Conmed Q4 Earnings - Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops - Yahoo Finance
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):